<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57858</article-id><article-id pub-id-type="doi">10.7554/eLife.57858</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Functional interrogation of <italic>HOXA9</italic> regulome in MLLr leukemia via reporter-based CRISPR/Cas9 screen</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-183333"><name><surname>Zhang</surname><given-names>Hao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183334"><name><surname>Zhang</surname><given-names>Yang</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1712-7211</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183345"><name><surname>Zhou</surname><given-names>Xinyue</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183335"><name><surname>Wright</surname><given-names>Shaela</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183336"><name><surname>Hyle</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183337"><name><surname>Zhao</surname><given-names>Lianzhong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183338"><name><surname>An</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183339"><name><surname>Zhao</surname><given-names>Xujie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183340"><name><surname>Shao</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183344"><name><surname>Xu</surname><given-names>Beisi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0099-858X</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183341"><name><surname>Lee</surname><given-names>Hyeong-Min</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9381-3611</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177171"><name><surname>Chen</surname><given-names>Taosheng</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6420-3809</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183342"><name><surname>Zhou</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-202561"><name><surname>Chen</surname><given-names>Xiang</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-183343"><name><surname>Lu</surname><given-names>Rui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-181818"><name><surname>Li</surname><given-names>Chunliang</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5938-5510</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Medicine - Hematology &amp; Oncology</institution>, <institution>University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Tumor Cell Biology</institution>, <institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Pharmaceutical Sciences</institution>, <institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Computational Biology</institution>, <institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Center for Applied Bioinformatics (CAB)</institution>, <institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Chemical Biology and Therapeutics</institution>, <institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States [US]</country></aff><aff id="aff8"><institution content-type="dept">School of Engineering</institution>, <institution>University of Alabama at Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Tumor Cell Biology</institution>, <institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-115383"><name><surname>Shi</surname><given-names>Xiaobing</given-names></name><role>Reviewing editor</role><aff><institution>Van Andel Institute</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>ruilu1@uabmc.edu</email> (RL);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>chunliang.li@stjude.org</email> (CL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>10</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e57858</elocation-id><history><date date-type="received"><day>15</day><month>04</month><year>2020</year></date><date date-type="accepted"><day>30</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Zhang et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Zhang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57858-v1.pdf"/><abstract><p>Aberrant <italic>HOXA9</italic> expression is a hallmark of most aggressive acute leukemias, notably those with KMT2A (MLL) gene rearrangements. <italic>HOXA9</italic> overexpression not only predicts poor diagnosis and outcome but also plays a critical role in leukemia transformation and maintenance. However, our current understanding of <italic>HOXA9</italic> regulation in leukemia is limited, hindering development of therapeutic strategies. Here, we generated the <italic>HOXA9-mCherry</italic> knock-in reporter cell lines to dissect <italic>HOXA9</italic> regulation. By utilizing the reporter and CRISPR/Cas9 screens, we identified transcription factors controlling <italic>HOXA9</italic> expression, including a novel regulator, USF2, whose depletion significantly down-regulated <italic>HOXA9</italic> expression and impaired MLLr leukemia cell proliferation. Ectopic expression of Hoxa9 rescued impaired leukemia cell proliferation upon USF2 loss. Cut&amp;Run analysis revealed the direct occupancy of USF2 at <italic>HOXA9</italic> promoter in MLLr leukemia cells. Collectively, the <italic>HOXA9</italic> reporter facilitated the functional interrogation of the <italic>HOXA9</italic> regulome and has advanced our understanding of the molecular regulation network in <italic>HOXA9</italic>-driven leukemia.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005968</institution-id><institution>Leukemia Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Lu</surname><given-names>Rui</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000048</institution-id><institution>American Cancer Society</institution></institution-wrap></funding-source><award-id>IRG15-59-IRG</award-id><principal-award-recipient><name><surname>Lu</surname><given-names>Rui</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>National Cancer Insititute</institution></institution-wrap></funding-source><award-id>P30CA021765-37</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Chunliang</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All plasmids created in this study will be deposited to Addgene. Raw data collected from Cut&amp;Run were deposited at NCBI GEO (GSE140664). Raw data collected from CRISPR screening were included in Supplementary File 2. Publicly available dataset used in this study were cited accordingly including Figures 1E and S5D: GSE120781; Figure 1-supplement 1A-C: GSE13159; Figure 3-supplement 2C: GSE126619, GSE74812, GSE89485; Figure 3-supplement 3A: ENCODE (HCT116); Figure 5-supplement 3A-C: European Genome-phenome Archive (EGA) under accession number EGAS00001003266, EGAS00001000654, EGAS00001001952, EGAS00001001923, EGAS00001002217 and EGAS00001000447.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Judith Hyle et al</collab></person-group><year iso-8601-date="2019">2019</year><source>Acute deletion of CTCF disrupted enhancer-promoter regulation of MYC in human cancer cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE120781">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE120781</ext-link><comment>NCBI Gene Expression Omnibus, GSE120781</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Wei-Min Liu et al</collab></person-group><year iso-8601-date="2008">2008</year><source>Microarray Innovations in LEukemia (MILE) study: Stage 1 data</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gds/?term=GSE13159[Accession]">https://www.ncbi.nlm.nih.gov/gds/?term=GSE13159[Accession]</ext-link><comment>NCBI Gene Expression Omnibus, GSE13159</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Judith Hyle et al</collab></person-group><year iso-8601-date="2019">2019</year><source>Acute deletion of CTCF disrupted enhancer-promoter regulation of MYC in human cancer cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gds/?term=GSE126619[Accession]">https://www.ncbi.nlm.nih.gov/gds/?term=GSE126619[Accession]</ext-link><comment>NCBI Gene Expression Omnibus, GSE126619</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Thomas Milne et al</collab></person-group><year iso-8601-date="2015">2015</year><source>MLL-rearranged acute lymphoblastic leukemias upregulate BCL-2 through H3K79 methylation and are highly sensitive to the BCL-2 specific antagonist ABT-199</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gds/?term=GSE74812[Accession]">https://www.ncbi.nlm.nih.gov/gds/?term=GSE74812[Accession]</ext-link><comment>NCBI Gene Expression Omnibus, GSE74812</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ali Shilatifard et al</collab></person-group><year iso-8601-date="2017">2017</year><source>Therapeutic targeting MLL degradation pathways in MLL-rearranged leukemia</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gds/?term=GSE89485[Accession]">https://www.ncbi.nlm.nih.gov/gds/?term=GSE89485[Accession]</ext-link><comment>NCBI Gene Expression Omnibus, GSE89485</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Zhaohui Gu et al</collab></person-group><year iso-8601-date="2019">2019</year><source>PAX5-driven Subtypes of B-cell Acute Lymphoblastic Leukemia</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001003266?order=type&amp;sort=asc">https://www.ebi.ac.uk/ega/studies/EGAS00001003266?order=type&amp;sort=asc</ext-link><comment>European Genome-phenome Archive, EGAS00001003266</comment></element-citation><element-citation id="dataset7" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Zhaohui Gu et al</collab></person-group><year iso-8601-date="2019">2019</year><source>PAX5-driven Subtypes of B-cell Acute Lymphoblastic Leukemia</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001000654">https://www.ebi.ac.uk/ega/studies/EGAS00001000654</ext-link><comment>European Genome-phenome Archive, EGAS00001000654</comment></element-citation><element-citation id="dataset8" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Zhaohui Gu et al</collab></person-group><year iso-8601-date="2019">2019</year><source>PAX5-driven Subtypes of B-cell Acute Lymphoblastic Leukemia</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001001952">https://www.ebi.ac.uk/ega/studies/EGAS00001001952</ext-link><comment>European Genome-phenome Archive, EGAS00001001952</comment></element-citation><element-citation id="dataset9" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Zhaohui Gu et al</collab></person-group><year iso-8601-date="2019">2019</year><source>PAX5-driven Subtypes of B-cell Acute Lymphoblastic Leukemia</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001001923">https://www.ebi.ac.uk/ega/studies/EGAS00001001923</ext-link><comment>European Genome-phenome Archive, EGAS00001001923</comment></element-citation><element-citation id="dataset10" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Zhaohui Gu et al</collab></person-group><year iso-8601-date="2019">2019</year><source>PAX5-driven Subtypes of B-cell Acute Lymphoblastic Leukemia</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001002217">https://www.ebi.ac.uk/ega/studies/EGAS00001002217</ext-link><comment>European Genome-phenome Archive, EGAS00001002217</comment></element-citation><element-citation id="dataset11" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Zhaohui Gu et al</collab></person-group><year iso-8601-date="2019">2019</year><source>PAX5-driven Subtypes of B-cell Acute Lymphoblastic Leukemia</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ega/studies/EGAS00001000447">https://www.ebi.ac.uk/ega/studies/EGAS00001000447</ext-link><comment>European Genome-phenome Archive, EGAS00001000447</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-57858-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>